Cargando…
Governing secondary research use of health data and specimens: the inequitable distribution of regulatory burden between federally funded and industry research
Some of the most promising recent advances in health research offer opportunities to improve diagnosis and therapy for millions of patients. They also require access to massive collections of health data and specimens. This need has generated an aggressive and lucrative push toward amassing troves o...
Autor principal: | Spector-Bagdady, Kayte |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8158426/ https://www.ncbi.nlm.nih.gov/pubmed/34055367 http://dx.doi.org/10.1093/jlb/lsab008 |
Ejemplares similares
-
Respiratory research funding is inadequate, inequitable, and a missed opportunity
por: Williams, Siân, et al.
Publicado: (2020) -
3313 “My research is their business, but I’m not their business”: Patient and Oncologist Perspectives on the Commercialization of Research Data
por: Spector-Bagdady, Kayte, et al.
Publicado: (2019) -
Accountability in patenting of federally funded research
por: Rai, Arti, et al.
Publicado: (2012) -
The Domino Effects of Federal Research Funding
por: Lanahan, Lauren, et al.
Publicado: (2016) -
Patient and Provider Perspectives on Enrollment in Precision Oncology Research: Qualitative Ethical Analysis
por: Spector-Bagdady, Kayte, et al.
Publicado: (2022)